一级运动员前交叉韧带重建后重返赛场与二次损伤影响因素:1432例两年随访
该研究前瞻性随访1432例由两名骨科医生行初次前交叉韧带重建的一级运动员,术后2年随访率超过95%。重返赛场率为81%,髌腱移植物同侧再断裂率为1.3%,腘绳肌腱移植物为8.3%(风险比0.17);对侧前交叉韧带损伤率为6.6%,随访时IKDC评分为86.8。重返赛场时间与二次前交叉韧带损伤无关,术前和术中变量预测结局能力较差。
要点
- 一级运动员前交叉韧带重建后2年重返赛场率为81%,对侧前交叉韧带损伤率为6.6%。
- 髌腱移植物同侧再断裂率为1.3%,腘绳肌腱移植物为8.3%,风险比0.17。
- 重返赛场时间与二次前交叉韧带损伤无关,术前和术中变量预测能力较差。
核心结论
- 一级运动员前交叉韧带重建后总体重返赛场率高,髌腱移植物再损伤率较低。
- 重返赛场时间对二次前交叉韧带损伤无影响。
- 术前和术中变量对结局的预测能力较差。
研究设计与样本
- 前瞻性队列研究,证据等级3级。
- 连续纳入1432例由两名骨科医生行初次前交叉韧带重建的一级运动员,术后随访超过2年。
主要发现
- 术后2年随访率超过95%,重返赛场率为81%。
- 重返赛场者中,髌腱移植物同侧再断裂率为1.3%,腘绳肌腱移植物为8.3%(风险比0.17)。
- 对侧前交叉韧带损伤率为6.6%,随访时IKDC评分为86.8。
- 髌腱移植物组IKDC评分低于80分的比例更高(比值比1.56;95%CI,1.15-3.12)。
- 重返赛场时间与二次前交叉韧带损伤无关,ACL-Return to Sport After Injury评分与重返赛场中度相关(P < .001,rho = 0.46)。
关键数值与推荐
- 重返赛场率81%,同侧再断裂率髌腱移植物1.3%、腘绳肌腱移植物8.3%(风险比0.17)。
- 对侧前交叉韧带损伤率6.6%,随访IKDC评分86.8。
- 髌腱移植物组IKDC评分低于80分的比值比1.56(95%CI,1.15-3.12)。
- ACL-Return to Sport After Injury评分与重返赛场相关(P < .001,rho = 0.46)。
临床怎么用
- 对于一级运动员,前交叉韧带重建后可预期较高的重返赛场率。
- 髌腱移植物可能与较低的同侧再断裂率相关,但需注意IKDC评分低于80分的比例较高。
- 重返赛场时间不应作为二次损伤风险的唯一考量,术前和术中变量预测能力有限。
局限性
- 术前和术中变量对结局的预测能力较差,可能需要探索身体和心理恢复等其他因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite the importance of return-to-play (RTP) rates, second anterior cruciate ligament (ACL) injury rates, and patient-reported outcomes of athletes returning to sports after ACL reconstruction (ACLR), these outcomes have not been evaluated together across a single cohort nor the pre- and intraoperative factors influencing outcomes explored. PURPOSE: To prospectively report outcomes after ACLR relating to RTP, second ACL injury, and International Knee Document Committee (IKDC) scores in a large cohort of athletes at a single center to examine the influence of pre- and intraoperative variables on these outcomes. DESIGN: Cohort study; Level of evidence, 3. METHODS: A consecutive cohort of 1432 athletes undergoing primary ACLR by 2 orthopaedic surgeons was followed up prospectively more than 2 years after surgery. Pre- and intraoperative findings were reported with outcomes at follow-up relating to RTP, second ACL injury, and IKDC. Between-group differences for each outcome were reported and the predictive ability of pre- and intraoperative variables relating to each outcome assessed with logistic regression. RESULTS: There was >95% follow-up 2 years after surgery. The RTP rate was 81%, and of those who returned, 1.3% of those with patellar tendon grafts and 8.3% of those with hamstring grafts experienced ipsilateral rerupture (hazard ratio, 0.17). The contralateral ACL injury rate was 6.6%, and the IKDC score at follow-up was 86.8, with a greater proportion of patients with patellar tendon grafts scoring <80 on the IKDC (odds ratio, 1.56; 95% CI, 1.15-3.12). There was no relationship between time to RTP and second ACL injury, and there was a moderate correlation between ACL-Return to Sport After Injury score and RTP at follow-up (P < .001, rho = 0.46). There were a number of differences in pre- and intraoperative variables between groups for each outcome, but they demonstrated a poor ability to predict outcomes in level 1 athletes at 2-year follow-up. CONCLUSION: Findings demonstrated high overall RTP rates, lower reinjury rates with patellar tendon graft after 2-year follow-up in level 1 athletes, and no influence of time to RTP on second ACL injury. Despite differences between groups, there was poor predictive ability of pre- and intraoperative variables. Results suggest pre- and intraoperative variables for consideration to optimize outcomes in level 1 athletes after ACLR, but future research exploring other factors, such as physical and psychological recovery, may be needed to improve outcome prediction after ACLR. REGISTRATION: NCT02771548 (ClinicalTrials.gov identifier).
引用
- King E, Richter C, Jackson M, et al. Factors Influencing Return to Play and Second Anterior Cruciate Ligament Injury Rates in Level 1 Athletes After Primary Anterior Cruciate Ligament Reconstruction: 2-Year Follow-up on 1432 Reconstructions at a Single Center. Am J Sports Med. 2020. PMID: 32031870. doi:10.1177/0363546519900170
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。